Larson et al. [47] and Zhan et al. [48] established SFTA3 as a diagnostic biomarker for lung adenocarcinoma, differentiating it from squamous cell carcinoma with high specificity. This evidence concerns the gene SFTA3 and squamous cell carcinoma.